Can lansoprazole enteric-coated capsules be reimbursed through medical insurance?

Lansoprazole/Daclopron (Lansoprazole) is a proton pump inhibitor (PPI), mainly used to inhibit gastric acid secretion to treat a variety of digestive system diseases. Its mechanism of action is to irreversibly inhibit H+/K+-ATPase in gastric parietal cells, significantly reducing gastric acid secretion and reducing gastric acid irritation to gastric mucosa and esophagus. This mechanism makes lansoprazole play an important role in the treatment of gastroesophageal reflux disease, peptic ulcer, duodenal ulcer, and protection against gastric ulcer caused by nonsteroidal anti-inflammatory drugs (NSAIDs). In addition, lansoprazole can also be used as an auxiliary drug in the Helicobacter pylori eradication treatment plan, used in combination with antibiotics to improve the success rate of treatment.

In clinical practice, lansoprazole is available in the form of oral capsules, orally disintegrating tablets or suspensions, and the dosage is adjusted according to the type of disease and individual patient differences. Its pharmacokinetic characteristics allow it to achieve the ideal acid-suppressing effect by taking it once a day, making it convenient for patients to manage chronic gastric diseases in the long term. Long-term use should be done under the guidance of a physician to avoid potential side effects such as mild diarrhea, headache, rash, or changes in vitamin and mineral absorption.

Regarding medical insurance reimbursement, lansoprazole has been launched in the country and is included in Class B medical insurance. This means that when patients meet the conditions for use of medical insurance, they can reimburse part of the drug cost through medical insurance, thus reducing their financial burden. However, reimbursement ratios and medication restrictions may differ in different regions. Patients should consult local medical insurance policies or pharmacies before purchasing to confirm the reimbursement amount and applicable conditions. Overall, lansoprazole is not only a commonly used proton pump inhibitor in clinical practice, but also has the advantage of medical insurance coverage, providing a safe and economical treatment option for patients with gastric acid-related diseases.

Reference materials:https://www.drugs.com/lansoprazole.html